20th October 2026, Tuesday

TechPharus

Latest Posts

HealthTech News

  • Low vitamin D use in patients on enzyme-inducing antiseizure drugs raises concerns
    on October 20, 2026 at 8:50 pm

    Enzyme-inducing antiseizure drugs (ASDs) are associated with increased odds of incident osteoporosis or osteopenia, but vitamin D supplementation is underutilized, according to a study presented at the annual meeting of the American Neurological Association, held from Oct. 17 to 20 in San Diego.

  • Fridge‑free vaccines could reach more people, but there are still practical challenges in African settings
    on October 20, 2026 at 8:40 pm

    Keeping vaccines and medicines at the right temperature is critical for their efficacy and safety. But this is an often overlooked part of getting them to the people who need them. In April 2025, the U.K. biotechnology company Stablepharma began the first human trial of a tetanus-diphtheria vaccine designed to remain stable without refrigeration. The development has renewed interest in technologies that could do the job, particularly in places where electricity, transport and storage infrastructure are limited. We spoke to immunization experts Charles Shey Wiysonge and Chinwe Juliana Iwu-Jaja about this.

  • Harnessing the heart’s natural defense against heart attack damage
    on October 20, 2026 at 8:40 pm

    Researchers are investigating whether the body’s built-in response to low oxygen can be harnessed to reduce heart damage during heart attacks and surgery, using drugs that are already available.

  • Q&A: Gene editing is coming for common diseases. Cardiologists discuss if we are ready
    on October 20, 2026 at 8:20 pm

    Gene therapy is no longer the future of medicine—it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.

  • New microscopy technology may help detect neurological diseases before neurons die
    on October 20, 2026 at 8:20 pm

    Scientists studying amyotrophic lateral sclerosis (ALS), Parkinson’s, Alzheimer’s and other neurological diseases are getting unprecedented views inside brain cells, using powerful new microscopes to uncover changes that may begin long before neurons die. These technologies enable researchers to zoom in on individual neurons and the tiny structures inside them, watch cells at work in real time and use artificial intelligence to identify patterns linked to disease, according to experts who spoke at the Oct. 18 Presidential Symposium—”Advances in Microscopy for Visualizing Neurologic Disease”—at the 151st Annual Meeting of the American Neurological Association (ANA 2026).